The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $113.69

Today's change+1.08 +0.96%
Updated November 28 1:00 PM EST. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $113.69

Today's change+1.08 +0.96%
Updated November 28 1:00 PM EST. Delayed by at least 15 minutes.

Celgene Corp Hits New 52-week High

Celgene Corp closed up Friday by (U.S.)$1.08 or 0.96% to (U.S.)$113.69 and setting a new 52-week high. Over the last five days, shares have gained 5.07% and 34.57% year to date. Shares have outperformed the S&P 500 by 26.15% during the last year.

Key company metrics

  • Open(U.S.) $113.45
  • Previous close(U.S.) $112.61
  • High(U.S.) $114.50
  • Low(U.S.) $112.80
  • Bid / Ask-- / --
  • YTD % change+34.57%
  • Volume2,543,978
  • Average volume (10-day)3,466,331
  • Average volume (1-month)4,183,935
  • Average volume (3-month)4,903,209
  • 52-week range(U.S.) $66.85 to (U.S.) $114.50
  • Beta1.09
  • Trailing P/E59.51×
  • P/E 1 year forward30.79×
  • Forward PEG1.20×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.91
Updated November 28 1:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.80%

Based on its net profit margin of 21.80%, Celgene Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,9821,8731,7301,756
Total other revenue--------
Total revenue1,9821,8731,7301,756
Gross profit1,8851,7741,6441,663
Total cost of revenue98998693
Total operating expense1,3381,1161,3681,430
Selling / general / administrative498492494449
Research & development675457714731
Depreciation / amortization64656666
Interest expense (income), net operating--------
Unusual expense (income)43992
Other operating expenses, total--------
Operating income645757362326
Interest income (expense), net non-operating-64-52-40-40
Gain (loss) on sale of assets--------
Other--------
Income before tax578707332217
Income after tax509598280214
Income tax, total69109533
Net income509598280214
Total adjustments to net income--------
Net income before extra. items509598280214
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items509598280214
Inc. avail. to common incl. extra. items509598280214
Diluted net income509598280214
Dilution adjustment--------
Diluted weighted average shares833831845859
Diluted EPS excluding extraordinary itemsvalue per share0.610.720.330.25
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.610.720.340.35